This compound is a pharmaceutical intermediate featuring a pyrrolo[2,3-d]pyrimidine core and piperidine ring with defined stereochemistry. It is primarily used in research and manufacturing settings for the synthesis of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Tofacitinib
pharmaceutical raw material
Tofacitinib citrate
pharmaceutical raw material
(3S,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile
pharmaceutical raw material
Gamma-Benzyl L-glutamate
pharmaceutical intermediate
N-Cbz-O-tert-butyl-L-serine
pharmaceutical intermediate
Boc-L-aspartic acid 4-tert-butyl ester
pharmaceutical intermediate
Fmoc-Thr(tBu)-Thr(Psi(Me,Me)pro)-OH
pharmaceutical intermediate
N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
research compound
3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanamide
CRDMXSMPTHMXRD-PWSUYJOCSA-N
C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC(=O)N
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.